ESM1 and cervical cancer: CRISPR/Cas9-mediated ESM1 KO inhibited cervical cancer cell proliferation (EdU-nuclei ratio decreasing, Fig. S2D) and cell cycle progression (causing G1-S arrest, Fig. S2E).